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TherolesofmultifunctionalCD4Tcellsinhumantuberculosisarenotwelldefined.Inthisstudy,wefound
that patientswithtuberculosishaddecreasedPMA/ionomycin stimulated multifunctional CD4T cells,and
increased Mycobacterium tuberculosis antigen-specific multifunctional CD4 T cells, when compared to
individuals with latent tuberculosis infection and healthy controls. PMA/ionomycin stimulated
IFN-c
1IL-2
1TNF-a
1 CD4 T cell responses were decreased in patients with smear-positive tuberculosis
comparedtothosewithsmear-negativetuberculosis.ThepercentageofIFN-c
1IL-2
1TNF-a
1CD4Tcellsin
smear positive tuberculosis patients negatively correlated with the grade of sputum smear Acid-Fast Bacilli
and high-resolution computed tomography score. Therefore, our findings argue against the notion that
Mycobacterium tuberculosis antigen-specific multifunctional Th1 responses in peripheral blood can serve
ascorrelatesofprotectiveimmunityagainsttuberculosis;theysuggestthatthedecreaseinPMA/ionomycin
stimulated IFN-c
1IL-2
1TNF-a
1 CD4 T cells may be applied for clinical diagnosis of active tuberculosis.
P
ulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tuberculosis) is one of the most
pervasive killers among infectious diseases
1. It has been generally accepted that CD4 T cell mediated
immunity plays an important role in control of the infectious bacillus
2,3. However, the characteristics of
protective immunity remain to be elucidated.
Recent studies have suggested that CD4 T cells simultaneously secreting IFN-c, TNF-a, and IL-2, which have
been termed as multifunctional Th1 cells, are associated with control of chronic bacterial and viral infections
4–6.
The presence of multifunctional Th1 cells in the lung has also been reported to correlate with protection against
Mycobacterium tuberculosis aerosol challenge in mice
7. In humans, some reports have suggested that multi-
functional M.tuberculosis-specific CD4 T cells play an important role in protective immunity against tuber-
culosis
8,9. However, Caccamo et al reported that multifunctional CD4T cells correlate with active M. tuberculosis
infection, instead of correlating with protective immunity
10. Similarly, studies in cynomolgus macaque tuber-
culosis models revealed that M. tuberculosis-specific multifunctional T cells are better correlates of antigen load
(i.e.,diseasestatus),thanofprotection
11.Whiletheseparadoxicalfindingsmaybeduetothedifferentpopulations
studied and the different protocols used
7,9–12, they clearly indicate further investigations are warranted to under-
stand the role of multifunctional Th1 cells in human tuberculosis.
To characterize multifunctional CD4 T cell responses associated with M. tuberculosis infection, we compared
PMA/ionomycin stimulated and M. tuberculosis-specific multifunctional CD4 T cell responses among TB
patients, patients with latent tuberculosis infection (LTBI), and healthy control individuals (HC). We also
evaluated the relationship between sputum smear positivity and multifunctional CD4 T cell response.
Furthermore, we assessed the severity of pulmonary tuberculosis by high-resolution computed tomography
(HRCT) score
13,14 and analyzed its association with multifunctional CD4 T cells.
Results
Patients with TB present decreased ex vivo PMA/ionomycin-stimulated multifunctional CD4 T cell
responses compared to LTBI and HC. We first compared expression of IFN-c, IL-2 and TNF-a in CD4 T
cells from patients with active TB, LTBI subjects, and HC, after short-term ex vivo stimulation with PMA/
ionomycin. Responding CD4 T cells were classified as triple (31), double (21) or single (11) cytokine-
producing populations according to expression profile of IFN-c, IL-2 and TNF-a (Figure 1A). As shown in
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SCIENTIFIC REPORTS | 2 : 216 | DOI: 10.1038/srep00216 1Figure 1B, while thereare no significant differences between HC and
LTBI, patients with TB had decreased percentages of IFN-c
1IL-
2
1TNF-a
1, IFN-c
1IL-2
1, and IFN-c
1TNF-a
1 producing CD4 T
cells, but increased TNF-a single positive CD4 T cells compared
with HC and LTBI. However, the relative proportion of 31 (IFN-
c
1IL-2
1TNF-a
1) CD4 T cells within total population of cytokine-
producing CD4 T cells is not significantly decreased in patients
with TB (Figure 1C), due to simultaneously decrease of 21 and
11 cytokine-producing CD4 T cell in patients with TB (Figure 1B).
Therefore, the frequency of 31 CD4 T cells within total CD4 T cells,
but not the relative proportion of 31 CD4 T cell within cytokine-
producing CD4 T cells, is associated with TB disease outcome.
M. tuberculosis-specific multifunctional CD4 T cell responses are
increased in patients with TB compared to LTBI and HC. In
contrast to PMA/ionomycin-stimulated multifunctional CD4 T
cell responses, patients with TB had significantly increased per-
centages of M. tuberculosis-specific 31 and 21 CD4 T cell
responses, when compared with LTBI and HC (Figure 2 A&B).
There are no significant differences between any of the single-
positive CD4 T cell responses among the three different populations
(Figure 2B). Accordingly, the relative proportions of 31 and 21 CD4
T cells were not significantly increased in TB (Figure 2C).
PMA/ionomycin-stimulated IFN-c
1IL-2
1TNF-a
1CD4Tcellsare
decreased in culture and smear-positive TB patients compared to
smear-negative ones, and correlates with the sputum smear Acid-
Fast bacilli. It has been reported that sputum smear positivity
in patients with TB correlated with disease severity and was asso-
ciated with response to anti-tuberculosis treatment
14–17.W ef o u n dt h a t
patients with sputum-culture negative TB had significantly increased
PMA/ionomycin-stimulated 31 cytokine-producing CD4 T cells
compared with patients with culture-positive TB (Figure 3A). There
were no significant differences in any other PMA/ionomycin-
stimulated 21 or 11 cytokine combinations of CD4 T cells found
between the two groups of TB patients (data not shown). Notably, a
significant negative correlation between percentage of 31 CD4 T cells
and sputum smear grade at diagnosis within smear-positive TB
patients was found (r 520.438, p50.0136) (Figure 3B). In contrast,
culture-negative TB patients had lower proportions of M. tuberculosis-
specific 31,2 1 (IFN-c
1 IL-2
1 and IFN-c
1 TNF-a
1), and 11 (IFN-
c
1) CD4 T cells than culture-positive TB patients, although these
differences did not attain statistical significance (Figure 4).
Correlation between PMA/ionomycin-stimulated IFN-c
1IL-
2
1TNF-a
1 CD4 T cell and HRCT score of pulmonary TB
patients. HRCT scores had been generated from 74 patients with
Figure 1 | Patients with TB present decreased PMA/ionomycin stimulated multifunctional CD4 T cell responses, compared with LTBI and HC. (A)
Whole blood from HC, LTBI, and TB patients was stimulated for 6 hrs with PMA/ionomycin and cells were analyzed by flow cytometry for intracellular
expression of IFN-c, IL-2, and TNF-a in CD4 (CD3
1CD8
2) T cells. (A) Representative dot plots show the gating procedure for analyzing cytokine
productionofCD4(CD3
1CD8
2)Tcells.(B)SummarycumulativedatashowthepercentageofCD4Tcellswithdifferentpatternsofcytokineproduction
in HC (n590), LTBI (n5108), and TB (n5131). Data were expressed as mean 6SEM. ** p,0.01, ***p,0.001. (C) The pie charts summarize the
fractions of single (11, green), double (21, blue), and Triple (31, red) CD4 T cell producers of IFN-c, IL-2, and TNF-a in HC, LTBI, and TB.
www.nature.com/scientificreports
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smear-positive TB patients, while the rest of patients were smear-
negative. Correlation analysis revealed that only PMA/ionomycin-
stimulated 31 CD4 T cells, but not any other subset of CD4 T cells,
significantly correlated with total HRCT score for all 74 patients
with TB, although the correlation efficient (Pearson’s r) was low
(Figure 5A). When the correlation analysis was performed within
the subgroup of smear-positive TB patients, a higher correlation
Figure 2 | Patients with TB demonstrate increased multifunctional CD4 T cell responses to TB antigens compared with LTBI and HC. (A) PBMCs
from HC, LTBI, and TBdonors were stimulatedfor 16 h with M. tuberculosis lysate andanalyzedbyflow cytometry for intracellular expressionof IFN-c,I L - 2 ,
and TNF-a in CD4 T cells. (A) Representative dot plots showed the gating procedure for analyzing cytokine production of CD4 (CD3
1CD8
-) T cells. (B)
Summary of cumulative data showing the percentages of CD4 T cells with different patterns of cytokine production in HC (n566), LTBI (n530), and TB
(n561). Data are expressed as mean 6SEM. *p,0.05, ** p,0.01, ***p,0.001. (C) The pie charts summarizing the fractions of single (11,g r e e n ) ,d o u b l e
(21,b l u e ) ,a n dt r i p l e( 3 1, red) CD4 T cell producers of IFN-c,I L - 2 ,a n dT N F - a in HC, LTBI, and TB.
Figure 3 | PMA/ionomycin stimulated 31 cytokine-producing CD4 T cell responses are associated with culture and sputum smear-positivity. Whole
blood of TB patients was stimulated with PMA/ionomycin, and IFN-c, IL-2, TNF-a cytokine production was analyzed as described in Figure 1. (A) The
percentage of 31 cytokine-producing CD4 T cells in TB patients with negative culture for M. tuberculosis [culture(-), n593] is higher compared with
those with positive cultures [culture(1), n537]. Each dot represents results for one patient. P value is indicated. (B) Correlation analysis between the
percentage of 31 cytokine-producing CD4 T cells and sputum smear grade in culture (1) TB patients (n532).
www.nature.com/scientificreports
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correlation between M. tuberculosis-specific multifunctional CD4 T
cell response and HRCT score (data not shown).
PMA/ionomycin stimulated IFN-c
1IL-2
1TNF-a
1 CD4 T cells are
correlated with Th17 cells in TB patients. It has been reported that
Th17 cells and IL-17 play important roles in protective immunity
against TB
18–20. Suppressed Th17 responses are associated with M.
tuberculosis infection, development, and severity of TB diseases in
humans
21,22.Therefore,itisimportanttounderstandtherelationship
between multifunctional CD4 T cells and theTh17 response. As
shown in Figure 6, PMA/ionomycin-stimulated 31 cytokine-
producing CD4 T cells correlate well with the frequency of Th17
cells regardless of donors’ disease status. Given our knowledge of
the roles played by Th17 cells in TB, these data suggest that there
may be similar or overlapping roles for PMA/ionomycin stimulated
31 CD4 T cells.
Discussion
CD4 T cells simultaneously expressing IFN-c,TNF-a, and IL-2
(termed multifunctional Th1 cells), have been reported to play a
critical role in controlling chronic bacterial and viral infections
4–6.
However, the inconsistent or controversial results generated so far
havemade it difficultto define therole of these cells in tuberculosis
7–11.
To better understand the role of multifunctional Th1 cells in TB, we
analyze the association between multifunctional Th1 cells and severity
of disease in TB patients, as defined by both sputum smear-grade and
HRCT score of pulmonary tuberculosis at diagnosis
13,14.C o n s i s t e n t
with most previous studies
7,9–11, our data showed that the percentage
of M. tuberculosis-specific multifunctional CD4 T cells are signifi-
cantly higher in TB patients than in LTBI and HC. However, we
did not find significant differences in multifunctional CD4 T cell
responses between smear-positive and smear negative TB patients,
which is inconsistent with two recent reports that M. tuberculosis-
specific multifunctional Th1 responses are associated with sputum
smear grading
9,23. In addition, there is no significant correlation
between antigen-specific multifunctional Th1 response and severity
of pulmonary tuberculosis defined by HRCT score and sputum smear
grading. Taken together, these results did not establish a direct asso-
ciation between the levels of antigen-specific multifunctional Th1 cell
response and mycobacterial antigen load. This inconsistency could be
due to the differences in study populations and experimental proto-
cols, for example, M. tuberculosis specific multifunctionalTh1cells are
memoryresponses to both BCG vaccination and M. tuberculosisinfec-
tion in our population. Alternatively, there are likely other mechan-
isms regulating multifunctional Th1 response during M. tuberculosis
infection that may interfere with this correlation
24. Whatever theexact
reason, our data argue against the notion that antigen-specific multi-
functional Th1 responses in peripheral bloodcanserveas correlates of
protective immunity against TB
25.
Interestingly, we found that PMA/ionomycin-stimulated multi-
functional Th1 cells are significantly decreased in patients with TB,
comparedtoLTBIandHC.Inaddition,patientwithsputum-culture
Figure 4 | Antigen-specific multifunctional CD4 T cell responses were not different between M. tuberculosis culture (-) (n538) and culture (1)
(n525) TB patients. PBMCs from TB patients were stimulated with M. tuberculosis lysate for 16 h and analyzed for IFN-c, IL-2, TNF-a cytokine
production as described in Figure 2. The percentages of CD4 T cells with different patterns of cytokine production were compared between the two
groups.
Figure 5 | The percentages of PMA/ionomycin stimulated 31 cytokine-producing CD4 T cells correlate with HRCT score in patients with TB.
Correlation analyses demonstrate significance between the percentage of 31 cytokine-producing CD4 T cells and HRCT score of pulmonary disease in
(A) TB patients (n574) regardless the positivity of sputum smear and (B) in smear-positive TB patients (n515).
www.nature.com/scientificreports
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31 cytokine-producing CD4 T cells compared with patients with
culture-positive TB. Moreover, PMA/ionomycin-stimulated 31
cytokine-producing CD4 T cell percentages significantly inversely
correlated with both smear grade and HRCT score. Previous studies
have indicated that sputum smear grading at the time of diagnosis
not only correlates with response to anti-tuberculosis treatment, but
also with disease severity by chest radiograph scoring
13,15,17. It is also
reported that smear grading is predicative of relapse and recurrence
of TB disease
15. Since PMA/ionomycin-stimulated multifunctional
Th1 cells were detected in whole blood with short-term PMA/iono-
mycin stimulation, presumably only antigen-experienced T cells can
be detected. Considering the fact that the frequency of M. tuber-
culosis-specific multifunctional Th1 is low (less than 0.1%); it is
probable that majority of PMA/ionomycin stimulated multifunc-
tional T cells are not M. tuberculosis-specific, but specific for other
microbes to which the individual has been exposed. Therefore, it is
intriguing to find that the frequency of PMA/ionomycin stimulated
multifunctional Th1 cells is decreased in patients with TB and cor-
relates with disease severity. It is well known that antigen-experi-
enced T cells, regardless of their specificity, are attracted to sites of
infection during tuberculosis
26,27. A previous report also demon-
stratedthat,eveninhealthyindividuals,therearesignificantlyhigher
frequencies of antigen-specific CD4
1 T cells against influenza, S.
pneumoniae,andM.tuberculosisinbronchoaveolarfluid(BAL)than
in peripheral blood
25. This is particularly true in the case of multi-
functional Th1 cells, as there are significantly higher proportions of
multifunctional Th1 cells in BAL than in peripheral blood
25.A s
demonstrated in HBV infection, the hepatic inflammation initiated
byHBVrecruitsnotonlyHBV-specificTcellstothesiteofinfection,
but also non-HBV specific antigen experienced T cells are recruited
as well, and these T cells outnumber the HBV-specific ones
28.
Therefore, it is highly possible that antigen-experienced multifunc-
tional Th1 cells as detected by short-term PMA/ionomycin stimu-
lation, which include both M. tuberculosis specific and non-M.
tuberculosis specific, are recruited to the site of diseases and result
in their decrease in peripheral blood. The finding that frequency of
PMA/ionomycin stimulated multifunctional Th1 cells inversely cor-
relates with severity of pulmonary TB suggests that more multifunc-
tional Th1 cells may infiltrate into the site of infection in patients
with more severe diseases, which is probably due to higher inflam-
matory cytokines/chemokines, such as IL-6, IL-1b and IL-11, pro-
ducedinthelung
29.Furtherstudiesarewarrantedtoinvestigatetheir
role in the pathogenesis of TB. This is important since interactions
between T cells responding to concurrent mycobacterial and influ-
enza infections have been reported to affect effector responses to
pathogens
30.
We have reported previously that Th17 response is decreased in
patients with TB when compare to LTBI
22. In addition, patients with
severeTBhavesignificantlylowerTh17responsethanthosewithmild
TB
22. Interestingly, we found in this study that PMA/ionomycin-
stimulated 31cytokine-producingCD4Tcellssignificantlycorrelated
with Th17 responses in HC, LTBI and TB patients. Given the fact
that multifunctional Th1 cells can secret IL-17
24, and that Th17 cells
can also produce other Th1 cytokines including TNF-a,I F N - c, and
IL-2
31–33,i ti sp r o b a b l et h a tm u l t i f u n c t i o n a lT h 1c e l l s ,a tl e a s ts o m eo f
31 cytokine-producing CD4 T cells, simultaneously secrete IL-17.
Further investigation is warranted to clarify these possibilities since
it may provide new insight for clinical implementation of multifunc-
tional Th1 and Th17 cells in TB.
In summary, we found significant differences in the profiles of M.
tuberculosis-specific and polyclonal non Ag-specific multifunctional
Th1 responses among individuals with TB, LTBI and HC. These
findings may be applied for clinical diagnosis of active TB from
LTBI. Further investigations on dynamic changes of lung multifunc-
tional Th1 cells, both M.tuberculosis-specific and non-specific, dur-
ing development and resolution of pulmonary TB, as well as their
relationshipstoseverityofdiseasewillimproveourunderstandingof
their roles in TB.
Methods
Patients and samples. A total of 329 participants including healthy control
individuals (HC, n590), individuals with LTBI (LTBI, n5108), and pulmonary TB
patients (TB, n5131) were recruited for this study from the city of Shenzhen, China.
All study participants gave written, informed consent for the study, which was
approved by Human Research Ethics Committee of Shenzhen Third People’s
Hospital. All subjects were $18 years of age and were sero-negative for HIV. The sex
ratios (male/female) of each groups are HC (43/47), LTBI (60/48), and TB (86/45).
The ages of each group (median [interquartile range]) were: HC, 28.0 (25.0–32.0);
LTBI, 28.0 (25.0–36.0); PTB, 32.0 (25.0–43.5). A previously established M.
tuberculosis–specific IFN-c enzyme-linked immunospot (ELISPOT) assay was used
to differentiate individuals with LTBI from true healthy controls
34. Diagnosis of
pulmonary tuberculosis (TB) was based on signs and symptoms, roentgenographic
findings (chest X-ray and/or HRCT) consistent with TB, sputum bacterium
examination, and response to anti-tuberculosis treatment. The number of bacilli in
sputum smears was counted according to World Health Organization Guidelines
with minor modifications
35. Briefly, at least 3 sequential sputum samples were
collectedfromeachpatientbeforestartinganti-tuberculosischemotherapyandAcid-
Fast Bacilli (AFB) were identified by Ziehl-Neelsen staining. Of 131 TB patients, 37
hadsputumpositivecultureforM.tuberculosis.Amongthem,32hadsputumpositive
smearmicroscopyforM.tuberculosisandweredividedinto4groupsaspergradingof
the sputum AFB smear: group I (sputum11,n 513): 1 to 9 AFB per 100 fields; group
II (sputum 21,n 511): 10 to 99 AFB per 100fields; group III (sputum 31,n56): 1 to
10 AFBperfieldin50fields;andgroupIV(sputum41,n52):Morethan10 AFBper
fieldin 20 fields). Sputum samples were classified according tothe highest number of
AFBperspecimen.Peripheralbloodsampleswereobtainedfromallsubjects.Clinical
samples from patients with TB were obtained within 7 days prior to initiating
standard anti-TB treatment.
Intracellular cytokine staining and flow cytometric analysis. Fresh heparinized
whole blood (250 ml/well) was incubated with phorbol myristate acetate (PMA;
50 ng/ml; Sigma-Aldrich, USA) and ionomycin (1 mg/ml;Sigma-Aldrich) for 2 hsat
37uC. Blood incubated with no stimulation served as negative controls. Brefeldin A
(10 mg/ml; Sigma-Aldrich) was then added and the incubation continued for an
Figure 6 | PMA/ionomycinstimulated31cytokine-producingCD4TcellscorrelatewithTh17responses. Correlationanalysisbetweenthepercentage
of 31 cytokine producing CD4 T cells and the frequency of Th17 cells in (A) HC [n527], in (B) LTBI [n520], and in (C)TB patients [n518].
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 216 | DOI: 10.1038/srep00216 5additional 4 h. Following the 6 h incubation, 2 mM EDTA was added for 10 min,
followed by red cell lysis. Cells were washed again in PBS, then stained with surface
mAbs against CD3 and CD8 , fixed with FACS Lysing Solution(BD Bioscience, San
Jose, USA), permeabilized with permeabilizing solution (BD Bioscience), and
intracellularlystainedwithmAbsagainstIFN-c,IL-2,TNF-a,andIL-17(allfromBD
Bioscience). Cells were then washed and fixed in 1% paraformaldehyde. At least 0.2
millioneventswereacquiredusing aFACSCanto(BDBiosciences, San Jose,CA),for
analysis using FACS Diva software (BD Biosciences).
To measure antigen-specific cytokine production, peripheral blood mononuclear
cells (PBMCs) were isolated from heparinized fresh whole blood as described prev-
iously
22. PBMCs were cultured in complete RPMI 1640 medium at a final concen-
tration of 1310
6/mL in the absence or presence of heat killed M. tuberculosis lysate
(10 mg/ml) and solubleanti-CD28 antibody (0.1 mg/ml ,eBiscience, San Diego, USA).
Cells were plated in a 24-well flat-bottom plate and incubated at 37uC in a 5% CO2
incubator. After 4 hrs culture, Brefeldin A (10 mg/ml; Sigma, The Netherlands) was
added, and the cell cultures were continued for an additional 12 hrs. Cell incubated
with anti-CD28 alone served as a negative control. After 16 hrs culture, cells were
stained with surface and intracellular cytokine antibodies for flow cytometric analysis
as described above.
HRCT examination and scoring. HRCT were performed at 10 mm section interval
(120 kV, 50–450 mAs), (1 mm slice thickness, 1.5 s scanning time) with a window
level between 2550 and 40 Hounsfield Units (HU) and window width between 300
and 1600 HU using the Toshiba Aquilion 64 CT Scanner (Toshiba, Tokyo, Japan).
HRCT scans were analyzed two independent chest radiologists and final conclusions
on the findingswere reached by means of consensus. The arbitrary scores were based
on the percentage of lung parenchyma abnormality as previously described
14.
Data analysis. Statistical testing was performed using GraphPad Prism v4.0a
software. For analysis of intracellular cytokine staining (ICS) assay data, differences
betweenthethreeparticipantgroupswerefirstassessedusingtheKruskal–Wallistest,
followed by the Dunn’s posttest. If those data were found tobe significant (p , 0.05),
pairwisecomparisonswereanalyzed using the Mann–Whitney Utest.Thedifference
betweensmear-positiveandsmear-negativegroupswascomparedbyunpairedt-test.
Correlations were assessed using Spearman’s rank correlation.
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